EUVIMEDEUVIMED entdecken
Crossref

A synthetic lethal approach to drug targeting of G-quadruplexes based on CX-5461

Meiyu Jin, Laurence H Hurley, Hong Xu

Bioorganic & Medicinal Chemistry Letters · 2023-07 · 91 · 129384

DOI: 10.1016/j.bmcl.2023.129384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2023-07. Verfasst von Meiyu Jin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Horizon Omics Biotech Limited, E3, North Lake Science Park B, Changchun, Jilin Province 13000, China. Hauptthemen laut MEDLINE: G-Quadruplexes, Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA G-quadruplex (G4) structures are enriched at human genome loci critical for cancer development, such as in oncogene promoters, telomeres, and rDNA. Medicinal chemistry approaches to developing drugs that target G4 structures date back to over 20 years ago. Small-molecule drugs were designed to target and stabilize G4 structures, thereby blocking replication and transcription, resulting in cancer cell death. CX-3543 (Quarfloxin) was the first G4-targeting drug to enter clinical trials in 2005; however, because of the lack of efficacy, it was withdrawn from Phase 2 clinical trials. Efficacy problems also occurred in the clinical trial of patients with advanced hematologic malignancies using CX-5461 (Pidnarulex), another G4-stabilizing drug. Only after the discovery of synthetic lethal (SL) interactions between Pidnarulex and the BRCA1/2-mediated homologous recombination (HR) pathway in 2017, promising clinical efficacy was achieved. In this case, Pidnarulex was used in a clinical trial to treat solid tumors deficient in BRCA2 and PALB2. The history of the development of Pidnarulex highlights the importance of SL in identifying cancer patients responsive to G4-targeting drugs. In order to identify additional cancer patients responsive to Pidnarulex, several genetic interaction screens have been performed with Pidnarulex and other G4-targeting drugs using human cancer cell lines or C. elegans. Screening results confirmed the synthetic lethal interaction between G4 stabilizers and HR genes and also uncovered other novel genetic interactions, including genes in other DNA damage repair pathways and genes in transcription, epigenetic, and RNA processing deficiencies. In addition to patient identification, synthetic lethality is also important for the design of drug combination therapy for G4-targeting drugs in order to achieve better clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

G-QuadruplexesNeoplasmsAnimalsHumansBRCA1 ProteinBRCA2 ProteinCaenorhabditis elegansNaphthyridinesBenzothiazoles

Stichwörter der Autor:innen

Clinical biomarkersCombination therapyG-quadruplexGenetic screenPidnarulexSynthetic lethality

Substanzen

BRCA1 ProteinBRCA2 ProteinBRCA1 protein, humanBRCA2 protein, humanCX 5461NaphthyridinesBenzothiazoles

Autor:innen und Institutionen

  • Horizon Omics Biotech Limited, E3, North Lake Science Park B, Changchun, Jilin Province 13000, China.
  • R. Ken Coit College of Pharmacy, 1703 E. Mabel St., University of Arizona, Tucson, AZ 85724, United States; Reglagene, 3320 N. Campbell Ave., Suite 200, Tucson, AZ 85719, United States. Electronic address: hurley@reglag…
  • Horizon Omics Biotech Limited, E3, North Lake Science Park B, Changchun, Jilin Province 13000, China. Electronic address: xuhong@horizondna.com.

Förderung

  • NCI NIH HHS

Zitieren

APA

Jin, M., Hurley, L. H., & Xu, H. (2023). A synthetic lethal approach to drug targeting of G-quadruplexes based on CX-5461. Bioorganic & Medicinal Chemistry Letters, 91, 129384. https://doi.org/10.1016/j.bmcl.2023.129384

Vancouver

Jin M, Hurley LH, Xu H. A synthetic lethal approach to drug targeting of G-quadruplexes based on CX-5461. Bioorganic & Medicinal Chemistry Letters. 2023;91:129384. doi:10.1016/j.bmcl.2023.129384

BibTeX
@article{Jin2023,
  author = {Jin, Meiyu and Hurley, Laurence H and Xu, Hong},
  title = {A synthetic lethal approach to drug targeting of G-quadruplexes based on CX-5461},
  journal = {Bioorganic & Medicinal Chemistry Letters},
  year = {2023},
  volume = {91},
  pages = {129384},
  doi = {10.1016/j.bmcl.2023.129384}
}
Kostenlos starten →